cephalothin has been researched along with pefloxacin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
Carret, G; Flandrois, JP; Guerillot, F | 1 |
Gracida, C; Melchor, JL | 1 |
1 trial(s) available for cephalothin and pefloxacin
Article | Year |
---|---|
Prophylactic antibiotics in renal transplantation.
Topics: 4-Quinolones; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Cephalothin; Fluoroquinolones; Humans; Kidney Transplantation; Longitudinal Studies; Pefloxacin; Prospective Studies; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
6 other study(ies) available for cephalothin and pefloxacin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
Mathematical model for comparison of time-killing curves.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cell Cycle; Cephalothin; Escherichia coli; Kinetics; Mathematical Computing; Microbial Sensitivity Tests; Models, Biological; Nalidixic Acid; Ofloxacin; Pefloxacin; Time Factors | 1993 |